Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy
1996

Changes in TGF-beta mRNA in Breast Cancer Patients on Tamoxifen

Sample size: 37 publication Evidence: moderate

Author Information

Author(s): J MacCallum, JC Keen, JMS Bartlett, AM Thompson, JM Dixon, WR Miller

Primary Institution: University Department of Surgery, Edinburgh Royal Infirmary

Hypothesis

Does tamoxifen therapy affect the expression of TGF-beta isoforms in breast cancer patients?

Conclusion

The study suggests that response to tamoxifen therapy may be associated with an increase in expression of specific TGF-beta isoforms in some tumours.

Supporting Evidence

  • All patients had tumours larger than 3 cm and were ER-rich.
  • 27 out of 37 patients responded to tamoxifen treatment.
  • Significant correlation was found between TGF-beta2 expression and treatment response.

Takeaway

This study looked at how a medicine called tamoxifen affects certain proteins in breast cancer. It found that some patients showed changes in these proteins when treated.

Methodology

Tumour samples were taken from patients before and during tamoxifen treatment, and mRNA levels of TGF-beta isoforms were assessed.

Limitations

The study did not find a general increase in TGF-beta expression with tamoxifen treatment, and results may vary due to tumour heterogeneity.

Participant Demographics

Patients were over 70 years old with oestrogen receptor-positive breast cancer.

Statistical Information

P-Value

0.018

Statistical Significance

p=0.018

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication